Abstract
To assess the effect of raloxifene on bone and joint pain, 24 postmenopausal women with back or knee pain or both were randomly divided into two groups, based on the chronological sequence of consultation, to be treated with 60 mg raloxifene and 1 μg alfacalcidol (RA)/day (group RA) or 1 μg alfacalcidol alone (A)/day (group A), respectively, for 6 months. Pain following knee loading (KL) by standing up from a chair and bending the knee by squatting, knee and spine loading (KSL) by walking horizontally and ascending and descending stairs, and spine loading (SL) by lying down supine on a bed and leaving the bed to stand was evaluated by electroalgometry (EAM), based on measurement of the fall of skin impedance, and a visual rating scale (VRS), recording subjective pain on a scale of 0–100 between no pain and unbearable pain. The two groups showed no significant difference as to age, indices of mineral metabolism, back and knee pain, and bone status. RA gave a significantly greater analgesic effect than A by both EAM (P = 0.0158) and VRS (P = 0.0268) on overall comparison of the mean response to all modalities of exercise loading. Paired comparison between pretreatment and posttreatment indicated a significant effect of RA by both EAM (P = 0.0045) and VRS (P = 0.0017), but not that of A. The analgesic effect was more clearly noted on combined knee–spine loading (KSL) and spine loading (SL) than simple knee loading (KL). Monthly comparison of the analgesic effect indicated a significantly better analgesic effect in the fifth month by VRS. RA effect greater than A was more evident by EAM than VRS and during months 3–6 than during 1–2 months, suggesting a slowly progressive effect of RA. Pain evaluation by EAM and VRS mostly gave parallel results, except for a few occasions such as knee loading and spine loading by sitting up and leaving a bed, when EAM detected a positive effect but VRS failed to do so. RA appeared to be more effective on bone and joint pain than A in postmenopausal women according to both EAM and VRS measurements.
Similar content being viewed by others
References
Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–349
Bettica P, Cline G, Hart DJ, Meyer J, Spector TD (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis; longitudinal results from the Chingford study. Arthritis Rheum 46:3178–3184
Wluka AE, Davis SP, Bailey M, Stuckey SL, Cicuttini FM (2001) Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 60:332–336
Scharla S, Oertel H, Helsberg K, Kessler F, Langer F, Nickelsen T (2006) Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration. Curr Med Res Opin 22:2393–2402
Papadokostakis G, Katonis P, Damilakis J, Hadjipavlou A (2005) Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis? Eur Spine J 14:977–981
Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D, Peterfy C, Visser M, Harris TB, Wang BW, Kritchevsky SB, Health, Aging and Body Composition Study (2004) The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50:3516–3525
Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y (2001) Fall of skin impedance and bone and joint pain. J Bone Miner Metab 19:175–179
Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y (2001) Analgesic effect of etidronate on degenerative joint disease. J Bone Miner Metab 19:251–256
Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2002) The effect of active absorbable algal calcium (AAACa) with collagen and other matrix components on back and joint pain and skin impedance. J Bone Miner Metab 20:298–302
Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2008) Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine. J Int Med Res 36:932–941
Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2009) Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. J Bone Miner Metab 27:234–239
Fujita T, Fujii Y, Nakamura T, Miyauchi A, Takagi Y (2000) Effect of avicatonin (chicken carbocalcitonin) on galvanic skin response: a randomized, prospective, double-blind controlled study for an objective assessment of pain. Calcif Tissue Int 66:243–247
Sadreddini S, Molaeefard M, Noshad H, Ardalan M, Asadi A (2008) Efficacy of raloxifene in treatment of fibromyalgia in menopausal women. Eur J Intern Med 19:350–355
Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK (2008) Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med 8:979–984
Hicks GE, Shardell M, Miller RR, Bandinelli S, Guralnik J, Cherubini A, Lauretani F, Ferrucci L (2008) Associations between vitamin D status and pain in older adults: the Invecchiare in Chianti Study. J Am Geriatr Soc 56:785–791
Bjorkman M, Sorva A, Tilvis R (2008) Vitamin D supplementation has no major effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. Aging Clin Exp Res 20:316–321
Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14:12–16
Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hypponen E (2009) Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis 68:817–822
Acknowledgments
Aid from the Lilly Research Grant Program for Bone and Mineral Research (Japan Osteoporosis Foundation) is acknowledged.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Fujita, T., Fujii, Y., Munezane, H. et al. Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis. J Bone Miner Metab 28, 477–484 (2010). https://doi.org/10.1007/s00774-009-0155-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-009-0155-6